pepsinogen (1-12) has been researched along with gastrin 17 in 1 studies
| Studies (pepsinogen (1-12)) | Trials (pepsinogen (1-12)) | Recent Studies (post-2010) (pepsinogen (1-12)) | Studies (gastrin 17) | Trials (gastrin 17) | Recent Studies (post-2010) (gastrin 17) |
|---|---|---|---|---|---|
| 12 | 0 | 0 | 412 | 22 | 91 |
| Protein | Taxonomy | pepsinogen (1-12) (IC50) | gastrin 17 (IC50) |
|---|---|---|---|
| Cholecystokinin receptor type A | Homo sapiens (human) | 0.8511 | |
| Gastrin/cholecystokinin type B receptor | Homo sapiens (human) | 0.0041 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kashin, SV; Kriukova, TV; Maev, IV; Mel'nikova, EV; Nadezhin, AS | 1 |
1 other study(ies) available for pepsinogen (1-12) and gastrin 17
| Article | Year |
|---|---|
[Serologic screening for preneoplastic pathology and early stomach cancer].
Topics: Adolescent; Adult; Aged; Female; Gastrins; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Screening; Middle Aged; Neoplasm Staging; Pepsinogen A; Peptide Fragments; Stomach Neoplasms; Young Adult | 2008 |